Innate Pharma S.A. (NASDAQ:IPHA) Q3 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for joining us, and welcome to the Innate Pharma Third Quarter 2025 Business Update and Financial Results.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 20,042 | $39,082 | -25% | 0% |
| 2. | Millennium Management Israel Englander | 0 | $0 | 0% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 53,564 | $103,378 | 0% | |
| 2. | 4,797 | $9,258 | 0% | |
| 3. | 2,281 | $4,402 | 0% | |
| 4. | 470 | $916 | 0% | |
| 5. | 307 | $593 | 0% |